APA (7th ed.) Citation

Peng, Z., Chen, P., Lu, J., Wan, Y., Zheng, Y., Ye, F., . . . Shen, L. Trastuzumab deruxtecan in patients from China with previously treated human epidermal growth factor receptor 2–positive locally advanced/metastatic gastric or gastroesophageal junction adenocarcinoma (DESTINY-Gastric06): Results from a single-arm, multicenter, phase 2 trialResearch in context. Elsevier.

Chicago Style (17th ed.) Citation

Peng, Zhi, et al. Trastuzumab Deruxtecan in Patients from China with Previously Treated Human Epidermal Growth Factor Receptor 2–positive Locally Advanced/metastatic Gastric or Gastroesophageal Junction Adenocarcinoma (DESTINY-Gastric06): Results from a Single-arm, Multicenter, Phase 2 TrialResearch in Context. Elsevier.

MLA (9th ed.) Citation

Peng, Zhi, et al. Trastuzumab Deruxtecan in Patients from China with Previously Treated Human Epidermal Growth Factor Receptor 2–positive Locally Advanced/metastatic Gastric or Gastroesophageal Junction Adenocarcinoma (DESTINY-Gastric06): Results from a Single-arm, Multicenter, Phase 2 TrialResearch in Context. Elsevier.